Advocacy at a Glance STEVEN GROSSMAN 9/28/12 Advocacy at a Glance STEVEN GROSSMAN 9/28/12 Meatless Monday and the Washington Monument syndrome Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/12 Advocacy at a Glance STEVEN GROSSMAN 9/23/12 Sequestration Update and more Read More Analysis and Commentary STEVEN GROSSMAN 9/23/12 Analysis and Commentary STEVEN GROSSMAN 9/23/12 The Impact of Sequestration: An Update and Commentary Read More Uncategorized STEVEN GROSSMAN 9/14/12 Uncategorized STEVEN GROSSMAN 9/14/12 OMB Report Suggests $318 Million Loss to FDA From Sequestration Read More Advocacy at a Glance STEVEN GROSSMAN 9/14/12 Advocacy at a Glance STEVEN GROSSMAN 9/14/12 Sequester Transparency Report and more Read More Analysis and Commentary STEVEN GROSSMAN 9/14/12 Analysis and Commentary STEVEN GROSSMAN 9/14/12 A Large and Unequal Hit on the FDA Read More What's in the Media? STEVEN GROSSMAN 9/11/12 What's in the Media? STEVEN GROSSMAN 9/11/12 Hamburg Speaks on Effect of Sequester on User Fees Read More What's in the Media? STEVEN GROSSMAN 9/10/12 What's in the Media? STEVEN GROSSMAN 9/10/12 More on Sequestration and the FDA Budget for FY 13 Read More Analysis and Commentary STEVEN GROSSMAN 9/8/12 Analysis and Commentary STEVEN GROSSMAN 9/8/12 Of 6-Month CRs and the Perils of Sequestration Read More Advocacy at a Glance STEVEN GROSSMAN 9/8/12 Advocacy at a Glance STEVEN GROSSMAN 9/8/12 Congress Back in Session Next Week and more Read More Uncategorized STEVEN GROSSMAN 9/4/12 Uncategorized STEVEN GROSSMAN 9/4/12 Sequestration Potentially to INCLUDE Industry User Fees Read More
Advocacy at a Glance STEVEN GROSSMAN 9/28/12 Advocacy at a Glance STEVEN GROSSMAN 9/28/12 Meatless Monday and the Washington Monument syndrome Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/12 Advocacy at a Glance STEVEN GROSSMAN 9/23/12 Sequestration Update and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/23/12 Analysis and Commentary STEVEN GROSSMAN 9/23/12 The Impact of Sequestration: An Update and Commentary Read More
Uncategorized STEVEN GROSSMAN 9/14/12 Uncategorized STEVEN GROSSMAN 9/14/12 OMB Report Suggests $318 Million Loss to FDA From Sequestration Read More
Advocacy at a Glance STEVEN GROSSMAN 9/14/12 Advocacy at a Glance STEVEN GROSSMAN 9/14/12 Sequester Transparency Report and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/14/12 Analysis and Commentary STEVEN GROSSMAN 9/14/12 A Large and Unequal Hit on the FDA Read More
What's in the Media? STEVEN GROSSMAN 9/11/12 What's in the Media? STEVEN GROSSMAN 9/11/12 Hamburg Speaks on Effect of Sequester on User Fees Read More
What's in the Media? STEVEN GROSSMAN 9/10/12 What's in the Media? STEVEN GROSSMAN 9/10/12 More on Sequestration and the FDA Budget for FY 13 Read More
Analysis and Commentary STEVEN GROSSMAN 9/8/12 Analysis and Commentary STEVEN GROSSMAN 9/8/12 Of 6-Month CRs and the Perils of Sequestration Read More
Advocacy at a Glance STEVEN GROSSMAN 9/8/12 Advocacy at a Glance STEVEN GROSSMAN 9/8/12 Congress Back in Session Next Week and more Read More
Uncategorized STEVEN GROSSMAN 9/4/12 Uncategorized STEVEN GROSSMAN 9/4/12 Sequestration Potentially to INCLUDE Industry User Fees Read More
